Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19160365.
- Also identified by DOI 10.1002/bjs.6459.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study analysed the correlation between [(18)F]fluorodeoxyglucose (FDG) uptake assessed by positron emission tomography (PET) in breast tumours, and histopathological and inmunohistochemical prognostic factors. FDG-PET was performed before surgery in 275 women with primary breast cancer. The standarized uptake value (SUV) was compared with histopathological findings after surgery. A positive relationship was found between the SUV and tumour size (r = 0.46, P < 0.001), axillary lymph node status (P < 0.001), histological type (P < 0.001), histological grade (P < 0.001), oestrogen receptor status (P < 0.001), p53 (P < 0.001) and Ki-67 (P < 0.001) expression. Multivariable linear regression showed that tumour size, histological grade, Ki-67 expression, oestrogen receptor status and histological type were significantly related to the SUV. The SUV is a preoperative and non-invasive metabolic factor that relates to some prognostic factors in breast cancer.
Medical subject headings
- Breast Neoplasms
- Carcinoma, Ductal, Breast
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Lobular
- Fluorodeoxyglucose F18
- Radiopharmaceuticals